Koers India Globalization Capital, Inc. Nyse
Aandelen
US45408X1000
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 1,24 mln. 1,14 mln. | Omzet 2025 * | 1,4 mln. 1,29 mln. | Marktkapitalisatie | 35,77 mln. 32,88 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -12 mln. -11,03 mln. | Nettowinst (verlies) 2025 * | -10 mln. -9,19 mln. | EV/omzet 2024 * | 28,8 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 25,6 x |
K/w-verhouding 2024 * |
-2,16
x | K/w-verhouding 2025 * |
-2,97
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 79,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29-04-05 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 09-05-18 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29-04-05 |
Richard Prins
CHM | Chairman | 67 | 01-05-07 |
Director/Board Member | 79 | 18-01-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,19% | 56,65 mld. | |
-6,14% | 39,44 mld. | |
+39,19% | 39,03 mld. | |
-6,65% | 26,86 mld. | |
+12,33% | 26,75 mld. | |
-21,78% | 19,03 mld. | |
-0,35% | 12,28 mld. | |
+24,18% | 12,26 mld. | |
+28,38% | 12,04 mld. |